In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Monday closed down -0.76%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.28%, and the Nasdaq 100 Index ($IUXX) ...

The S&P 500 Index ($SPX) (SPY) today is down -0.95%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.51%, and the ...

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%.

Moderna (MRNA) closed the latest trading day at $41.66, indicating a +0.6% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily loss of 1.46%. Elsewhere ...

Moderna (MRNA) closed down more than -9% after Goldman Sachs downgraded the stock to neutral from buy, and TD Cown cut its price target on the stock to $35 from $55. Lennox International (LII ...

Moderna (MRNA) closed at $34.45 in the latest trading session, marking a -1.98% move from the prior day. The stock trailed the S&P 500, which registered a daily gain of 0.12%. Meanwhile ...